Sean R. Lucas, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1017 Ashes Dr, Suite 206, Wilmington, NC 28405 Phone: 910-239-9584 Fax: 910-679-4086 |
Alex Garhoe Yip, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1017 Ashes Dr, Suite 206, Wilmington, NC 28405 Phone: 910-239-9584 Fax: 910-679-4086 |
Kenneth William Myers, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1017 Ashes Dr, Suite 206, Wilmington, NC 28405 Phone: 910-239-9584 Fax: 910-679-4086 |
Dimitri Zivko Pitovski, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1099 Medical Center Dr Unit 100b, Wilmington, NC 28401 Phone: 910-399-2882 Fax: 866-336-5949 |
Katherine Laura Tison, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1017 Ashes Dr Ste 206, Wilmington, NC 28405 Phone: 910-239-9584 Fax: 910-679-4086 |
Anusha Vadlamudi, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1017 Ashes Dr Ste 206, Wilmington, NC 28405 Phone: 910-239-9584 Fax: 910-679-4086 |
Donald Miles Macqueen, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2321 Delaney Rd, Wilmington, NC 28403 Phone: 910-763-1661 Fax: 910-251-8595 |
News Archive
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
Many families beat the summer heat with trips to swimming pools, beaches, and water parks; but water safety concerns are particularly heightened for families of children with autism, said Varleisha Gibbs, OTD, OTR/L, occupational therapy professor at University of the Sciences in Philadelphia.
The National Institute of Environmental Health Sciences (NIEHS) has awarded Cornell insecticide toxicologist David Soderlund two grants, providing more than $2.5 million over five years, to study how insecticides affect human health.
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, today announced the recipients of the 2012 Avant-Garde Award for HIV/AIDS Research. The three scientists, Drs. David Smith, Samuel Friedman and Jeremy Luban, will each receive $500,000 per year for five years to support their research.
Galera Therapeutics, a drug development company focused on novel therapeutics to protect against the side effects and increase the effectiveness of cancer treatment, today announced it has completed a Series 1 financing led by BioGenerator. Also participating in the round is Galera Angels, LLC, an angel investment group, and Analytical Bio-Chemistry Laboratories, Inc., of Columbia Missouri.
› Verified 8 days ago